Harm from Stenting of Symptomatic Intracranial Arterial Stenoses
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenoses
Chimowitz MI, Lynn MJ, Derdeyn CP, et al; SAMMPRIS Trial Investigators. NEJM. 2011;365:993-1003
BACKGROUND
Atherosclerotic intracranial arterial stenosis represents a common cause of ischemic stroke. Patients with severe stenosis are at a high risk of recurrent stroke in the territory supplied by the stenotic artery. Percutaneous transluminal angioplasty and stenting (PTAS) of intracranial arterial stenosis was increasingly used to prevent recurrent strokes. At the time of this study, there was uncertainty regarding the optimal treatment of intracranial arterial stenosis with aggressive medical therapy alone vs. in combination with PTAS.
OBJECTIVES
To compare maximum medical therapy with PTAS for secondary ischemic stroke prevention in recently symptomatic patients with intracranial arterial stenosis.
METHODS
Prospective, randomized study at 50 centers across the United States between 2008 and 2011.
Patients
451 patients who experienced a TIA or nondisabling stroke secondary to an angiographically confirmed stenosis of 70% to 90% within 30 days before enrollment were randomized. There was no significant difference in the degree of stenosis or location of the qualifying artery between groups.
Interventions
Aggressive medical management (MM) consisted of aspirin 325 mg and clopidogrel 75 mg daily for 90 days after enrollment, systolic blood pressure < 140 mm Hg, and low-density lipoprotein (LDL) < 70 mg/dL. The PTAS group received aggressive MM and underwent placement of a Wingspan stent across the lesion.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


